Validation of Insulin-Like Growth Factor-1 as a Prognostic Parameter in Patients With Hepatocellular Carcinoma in a European Cohort
BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4677-y
Full Text
Open PDFAbstract
Available in full text
Date
July 31, 2018
Authors
Publisher
Springer Science and Business Media LLC